Cargando…

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer

BACKGROUND: Biomarkers of DNA damage repair deficiency provide opportunities for personalized treatment with immunotherapy. However, there is limited research on the immune microenvironment of adeno-neuroendocrine prostate cancer (NEPC). In this study, we aimed to assess and describe the comprehensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Gang, Zhang, Huaru, Shi, Haoqing, Zhang, Wenhui, Wang, Tao, Wang, Ziwei, Chen, Qing, Lian, Bijun, Li, Jing, Yang, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793563/ https://www.ncbi.nlm.nih.gov/pubmed/36572885 http://dx.doi.org/10.1186/s12957-022-02841-6

Ejemplares similares

Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer
por: Wang, Ziwei, et al.
Publicado: (2022)

Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
por: Zhang, Wenhui, et al.
Publicado: (2021)

Case Report: Systemic Treatment and Serial Genomic Sequencing of Metastatic Prostate Adenocarcinoma Progressing to Small Cell Carcinoma
por: Lu, XiaoJun, et al.
Publicado: (2021)

A genomic mutation spectrum of collecting duct carcinoma in the Chinese population
por: Zhang, Huaru, et al.
Publicado: (2022)

Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
por: Minagawa, Hideyuki, et al.
Publicado: (2021)

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases
por: Zhang, Qingfu, et al.
Publicado: (2021)

The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer
por: Cheng, Siyuan, et al.
Publicado: (2020)

Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters
por: Myint, Zin W., et al.
Publicado: (2021)

Clinicopathologic Significance of Gastric Adenocarcinoma with Neuroendocrine Features
por: Kim, Jang Jin, et al.
Publicado: (2011)

Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
por: Aytac, Berna, et al.
Publicado: (2011)

ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients
por: Suh, Ja Hee, et al.
Publicado: (2012)

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
por: Hingorani, Rittu, et al.
Publicado: (2014)

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
por: Ostano, Paola, et al.
Publicado: (2020)

Obstructive Jaundice: An Unusual Presentation of Neuroendocrine Differentiation in Prostatic Adenocarcinoma
por: Santhosh, Sampath, et al.
Publicado: (2021)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021)

A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago
por: Hosein, Ian, et al.
Publicado: (2016)

Transperineal Parallel Biopsy of the Prostate: A New Approach of Tissue Sampling for Precision Medicine
por: Qu, Min, et al.
Publicado: (2021)

Neuroendocrine Differentiation In Prostate Adenocarcinoma Biopsies And Its Correlation To Histological Grading
por: Marcu, Mădălina, et al.
Publicado: (2010)

Integrative Epigenome Map of the Normal Human Prostate Provides Insights Into Prostate Cancer Predisposition
por: Wang, Tao, et al.
Publicado: (2021)

Clinicopathological Characteristics and Prognostic Profiles of Breast Carcinoma with Neuroendocrine Features
por: Qiu, Yue, et al.
Publicado: (2023)

Clear cell adenocarcinoma of the prostatic urethra with metachronous prostate adenocarcinoma
por: Wang, Henry, et al.
Publicado: (2023)

Imaging of Neuroendocrine Prostatic Carcinoma
por: Taher, Ahmed, et al.
Publicado: (2021)

Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
por: Qiu, Xiaofu, et al.
Publicado: (2019)

Prostate sclerosing adenopathy: A clinicopathological and immunohistochemical study of twelve patients
por: Feng, Run-Lin, et al.
Publicado: (2022)

Smoothened loss is a characteristic of neuroendocrine prostate cancer
por: Wang, Lili, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for neuroendocrine prostate cancer, based on the SEER database
por: Chen, Siming, et al.
Publicado: (2023)

Profiling and bioinformatics analyses of differential circular RNA expression in prostate cancer cells
por: Zhang, Chunlei, et al.
Publicado: (2018)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Polycomb-mediated silencing in neuroendocrine prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2015)

Clinicopathological study of 9 cases of prostate cancer involving the rectal wall
por: Tang, Tao, et al.
Publicado: (2017)

Association of ABO Blood Types and Clinicopathological Features of Prostate Cancer
por: Wang, Fang-Ming, et al.
Publicado: (2017)

Multi-Omics Analyses Detail Metabolic Reprogramming in Lipids, Carnitines, and Use of Glycolytic Intermediates between Prostate Small Cell Neuroendocrine Carcinoma and Prostate Adenocarcinoma
por: Gao, Bei, et al.
Publicado: (2019)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Deciphering the enigma of neuroendocrine prostate cancer
por: Karzai, Fatima, et al.
Publicado: (2022)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
por: Habibian, David J., et al.
Publicado: (2016)

SIRT1 contributes to neuroendocrine differentiation of prostate cancer
por: Ruan, Lin, et al.
Publicado: (2017)

“Splice” a way towards neuroendocrine prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2018)

Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma
por: Qiao, Shaoyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lk0m611qdoij3ln4rqhsjefkb